Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer...

por Hansen, Henrik H., Fabricius, Katrine, Barkholt, Pernille, Kongsbak-Wismann, Pernille, Schlumberger, Chantal, Jelsing, Jacob, Terwel, Dick, Termont, Annelies, Pyke, Charles, Knudsen, Lotte Bjerre, Vrang, Niels
Publicado 2016

The endogenous preproglucagon system is not essential for gut growth homeostasis in mice

por Wismann, Pernille, Barkholt, Pernille, Secher, Thomas, Vrang, Niels, Hansen, Henrik B., Jeppesen, Palle Bekker, Baggio, Laurie L., Koehler, Jacqueline A., Drucker, Daniel J., Sandoval, Darleen A., Jelsing, Jacob
Publicado 2017

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice

por Madsen, Mette Simone Aae, Holm, Jacob Bak, Pallejà, Albert, Wismann, Pernille, Fabricius, Katrine, Rigbolt, Kristoffer, Mikkelsen, Martin, Sommer, Morten, Jelsing, Jacob, Nielsen, Henrik Bjørn, Vrang, Niels, Hansen, Henrik H.
Publicado 2019